A coalition of Republican senators led by Senator John Cornyn (R-TX) sent a letter to the Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) on Thursday, urging the agency to rescind several ...
Q4 2024 Management View CEO Olivier Loeillot highlighted that Repligen achieved Q4 2024 revenue of $167.5 million and full-year revenue of $634.4 million, meeting the midpoint of their November ...
YORVIPATH is a first-in-class PTH replacement therapy. A prodrug of parathyroid hormone (PTH [1-34]), YORVIPATH is administered subcutaneously once daily, with sustained release of active PTH designed ...